Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Hormonal therapies are safe and effective for treating adult women's acne.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Hair loss drugs may cause sexual issues and infertility in men.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

The document concludes that diagnosing PCOS requires a thorough approach, considering various symptoms and risks, and calls for improved methods to identify PCOS types and prevent diabetes.

PCOS is a common hormonal disorder in women, causing symptoms like acne and irregular periods, and is managed with medication and lifestyle changes.

The document concludes that transsexual individuals often experience improved quality of life after transitioning, despite higher risks of psychiatric issues and mortality.

Primary care is key in managing PCOS, focusing on lifestyle changes and medications like birth control and metformin.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Ursolic acid can shrink the prostate and lower a hormone linked to prostate growth in rats.

Skin changes in women with PCOS are mainly due to hormonal imbalances.

Metformin is less effective in men with early-onset hair loss.

Agaricus subrufescens extract improved ovarian function and normalized various health markers in rats with PCOS.

Women with and without PCOS show no significant differences in psychopathic traits.

High androgen levels in postmenopausal women may suggest an ovarian tumor, and removing it can improve heart and metabolic health.

Tripterygium wilfordii multiglycoside effectively reduced prostate enlargement in rats without harmful effects.

Agaricus subrufescens improves ovarian function and biochemical health in rats with PCOS.

A 36-year-old person with a female appearance but male chromosomes was diagnosed with a rare enzyme deficiency affecting sexual development.

Genes and epigenetic changes are important in the development of Polycystic Ovary Syndrome.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Androgens, male hormones, affect physical and mental functions, with a decrease leading to health issues like muscle loss, bone disease, and depression, and more research is needed on long-term effects and treatments.

High BMI worsens hair growth in women with PCOS.

Androgenetic alopecia negatively affects self-esteem and daily stress, especially in young men.

PCOS causes infertility mainly due to hormonal imbalances, insulin resistance, and chronic inflammation.

The conclusion is that obesity should be managed with a slow, balanced approach to diet and exercise, with medication and surgery as additional options, and education and access to care are important.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

Smoking may worsen hair loss, but more research is needed.

Lifestyle changes like diet and exercise are key for treating overweight women with polycystic ovary syndrome.

Finasteride improves immune response and reduces organ damage after trauma hemorrhage in mice.